A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
PHASE3CompletedINTERVENTIONAL
Enrollment
291
Participants
Timeline
Start Date
March 31, 2001
Study Completion Date
December 31, 2001
Conditions
Bipolar DisorderManic Episode
Interventions
DRUG
Risperidone, oral tablets
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00249236 - A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder | Biotech Hunter | Biotech Hunter